Live tape
Top 8, mentions 7d28,009NVDA16,803 mentions▲ +0.03MSFT1,909 mentions-0.02AMD1,891 mentions▲ +0.10GOOGL1,869 mentions▲ +0.04AAPL1,527 mentions▲ +0.05SPCX1,463 mentions▲ +0.07SPY1,351 mentions▲ +0.05NBIS1,196 mentions▲ +0.07

Equity · Healthcare

VVOS

NASDAQ

Vivos Therapeutics (VVOS)

0.4156 USD +2.29% vs prior close
Vivos Therapeutics, Inc. price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Track this symbol on TradingView
Market cap
8.4M USD
Revenue, year to Dec 2025
17.4M USD
EPS, diluted, year to Dec 2025
−2.07 USD
Avg volume
116.4K

as of Jul 17, 2026

Have Vivos Therapeutics (VVOS) insiders bought or sold shares recently?

VVOS's newest Form 4 filing is dated 31 July 2026: none in the last 90 days.

Form 4

Have Vivos Therapeutics (VVOS) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
31 Mar 2026Skaff Michael C10% OwnerBuy1,353,6251.8M USD
2 other filings: grants, exercises, tax withholding and transfers, not trades
Have Vivos Therapeutics (VVOS) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
31 Jul 2026Amman Bradford K.Principal Accounting OfficerAward250,000103K USD
30 Jun 2026Huntsman Ronald KirkChief Executive OfficerOther85,91050K USD

Which funds hold Vivos Therapeutics (VVOS)?

0 of the 45 institutional funds we track reported a Vivos Therapeutics position for the quarter ended 31 Dec 2025; the latest of those filings landed 12 Feb 2026.

Form 13F

Which funds hold Vivos Therapeutics (VVOS)?
FundPositionSharesValueShares q/q
Renaissance TechnologiesExited

What has been filed or recorded for Vivos Therapeutics (VVOS)?

The filings we hold for Vivos Therapeutics, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 09 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Vivos Therapeutics (VVOS)?
And
09 Oct 2026Fails to deliverShares failed to deliver1,359 shares204 USD notional · 0.007% of shares out
05 Oct 2026Fails to deliverShares failed to deliver34,762 shares5K USD notional · 0.173% of shares out
01 Oct 2026Fails to deliverShares failed to deliver10,000 shares2K USD notional · 0.050% of shares out
30 Sep 2026Fails to deliverShares failed to deliver570,147 shares86K USD notional · 2.834% of shares out
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.31 USDRevenue $5M
30 Jun 2026FinancialsTotal assets24.1M USDat period end
30 Jun 2026FinancialsTotal equity−3.8M USDat period end
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.52 USDRevenue $5M
31 Dec 2025Annual reportFY 2025 reportedEPS −2.07 USDRevenue $17M
31 Dec 2025FinancialsRevenue17.4M USDfiscal year
31 Dec 2025FinancialsNet income−21.2M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−2.07 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.49 USDRevenue $7M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.55 USDRevenue $4M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.45 USDRevenue $3M
31 Dec 2024Annual reportFY 2024 reportedEPS −2.22 USDRevenue $15M
30 Sep 2024Quarterly earningsQ3 2024 reportedEPS −0.40 USDRevenue $4M

What do people ask about Vivos Therapeutics (VVOS)?

From live data
What is Vivos Therapeutics’ market cap?8.4M

Vivos Therapeutics is worth 8.4M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.

What is Vivos Therapeutics’ revenue?17.4M

Vivos Therapeutics reported revenue of 17.4M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Vivos Therapeutics insiders bought or sold shares recently?

No Vivos Therapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 31 Jul 2026 (SEC Form 4). See Insiders

Which funds own Vivos Therapeutics?0 of 45

0 of the 45 funds we track reported a Vivos Therapeutics position for the quarter ended 31 Dec 2025, per their SEC Form 13F filings. The largest reported position was Renaissance Technologies. See Funds

When did Vivos Therapeutics last report earnings?−0.31

Vivos Therapeutics last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.31 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings